CRL vs DOCS · rev $4.05B vs P/E 21, rev $570.4M
Charles River Laboratories (CRL) versus Doximity Inc (DOCS) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Doximity Inc (DOCS) is a health information services company listed on US.
Latest reported CRL revenue for 2024-12-28 was $4.05B. Net income was $25.3M. Revenue was down 1.9% from 2023-12-30 to 2024-12-28. CRL currently screens at market cap $7.78B.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
CRL currently screens at market cap $7.78B. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Not investment advice. Open the CRL and DOCS stock pages for the full models.
Not investment advice.